Compounds > fludarabine

fludarabine and Wiskott-Aldrich Syndrome

fludarabine has been researched along with Wiskott-Aldrich Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azik, F; Emir, S; Erdem, AY; Isik, P; Metin, A; Tavil, B; Tunc, B; Uckan, D1
Bureo, E; Diaz de Heredia, C; Gonzalez-Vicent, M; Maldonado, MS; Martinez, A; Muñoz, A; Olivé, T; Sastre, A1
Cavenagh, J; Edgar, JD; Haque, T; Helbert, MR; Longhurst, HJ; Syndercombe-Court, D; Taussig, D1

Other Studies

3 other study(ies) available for fludarabine and Wiskott-Aldrich Syndrome

ArticleYear
Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
    Pediatric transplantation, 2013, Volume: 17, Issue:6

    Topics: Antilymphocyte Serum; Blood Platelets; Busulfan; Child; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neutrophils; Remission Induction; Siblings; Transplantation Conditioning; Treatment Outcome; Vidarabine; Wiskott-Aldrich Syndrome

2013
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:6

    Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Depletion; Male; Melphalan; Multiple Organ Failure; Postoperative Complications; Reoperation; Retrospective Studies; Spain; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Wiskott-Aldrich Syndrome

2007
Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome.
    British journal of haematology, 2002, Volume: 116, Issue:2

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Penicillin V; Transplantation Chimera; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine; Wiskott-Aldrich Syndrome

2002